{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:27:03Z","timestamp":1707524823718},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,7]]},"DOI":"10.7759\/cureus.32303","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T04:14:15Z","timestamp":1670472855000},"source":"Crossref","is-referenced-by-count":0,"title":["Steven Johnson Syndrome in a 102-Year-Old Woman in Saudi Arabia: A Case Report"],"prefix":"10.7759","author":[{"given":"Yasser H","family":"Alnofaiey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wjood A","family":"AlTalhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wahaj A","family":"Altalhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer I","family":"Alsulaimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layla M","family":"Alkhaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau JC","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, et al.. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995, 333:1600-8. 10.1056\/NEJM199512143332404","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05418-X","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: A case-control study","volume":"353","author":"Rzany B","year":"1999","unstructured":"Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: A case-control study. Lancet. 1999, 353:2190-4. 10.1016\/S0140-6736(98)05418-X","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.146165","article-title":"Cutaneous adverse drug reactions in Indian population: A systematic review","volume":"5","author":"Patel TK","year":"2014","unstructured":"Patel TK, Thakkar SH, Sharma D. Cutaneous adverse drug reactions in Indian population: A systematic review. Indian Dermatol Online J. 2014, 5:S76-86. 10.4103\/2229-5178.146165","journal-title":"Indian Dermatol Online J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2569-3","article-title":"Incidence of Stevens-Johnson syndrome\/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study","volume":"75","author":"Rodr\u00edguez-Mart\u00edn S","year":"2019","unstructured":"Rodr\u00edguez-Mart\u00edn S, Mart\u00edn-Merino E, Lerma V, et al.. Incidence of Stevens-Johnson syndrome\/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study. Eur J Clin Pharmacol. 2019, 75:237-46. 10.1007\/s00228-018-2569-3","journal-title":"Eur J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1923","article-title":"Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis","volume":"123","author":"Levi N","year":"2009","unstructured":"Levi N, Bastuji-Garin S, Mockenhaupt M, et al.. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009, 123:e297-304. 10.1542\/peds.2008-1923","journal-title":"Pediatrics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt M","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, et al.. Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008, 128:35-44. 10.1038\/sj.jid.5701033","journal-title":"J Invest Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12355","article-title":"Paracetamol induced Stevens-Johnson syndrome--toxic epidermal necrolysis overlap syndrome","volume":"53","author":"Biswal S","year":"2014","unstructured":"Biswal S, Sahoo SS. Paracetamol induced Stevens-Johnson syndrome--toxic epidermal necrolysis overlap syndrome. Int J Dermatol. 2014, 53:1042-4. 10.1111\/ijd.12355","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12754","article-title":"Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis","volume":"44","author":"Nguyen KD","year":"2019","unstructured":"Nguyen KD, Tran TN, Nguyen MT, et al.. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis. J Clin Pharm Ther. 2019, 44:69-77. 10.1111\/jcpt.12754","journal-title":"J Clin Pharm Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.10.033","article-title":"Epidermal necrolysis, ocular complications, and \"Cold Medicines\"","volume":"6","author":"Roujeau JC","year":"2018","unstructured":"Roujeau JC, Dunant A, Mockenhaupt M. Epidermal necrolysis, ocular complications, and \"Cold Medicines\". J Allergy Clin Immunol Pract. 2018, 6:703-4. 10.1016\/j.jaip.2017.10.033","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1992.00400190131024","article-title":"Herpes simplex virus associated with recurrent Stevens-Johnson syndrome: a management strategy","volume":"152","author":"Detjen PF","year":"1992","unstructured":"Detjen PF, Patterson R, Noskin GA, Phair JP, Loyd SO. Herpes simplex virus associated with recurrent Stevens-Johnson syndrome: a management strategy. Arch Intern Med. 1992, 152:1513-6. 10.1001\/archinte.1992.00400190131024","journal-title":"Arch Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.07.044","article-title":"Mycoplasma pneumoniae-induced Stevens-Johnson syndrome without skin lesions: fact or fiction?","volume":"52","author":"Schalock PC","year":"2005","unstructured":"Schalock PC, Dinulos JG. Mycoplasma pneumoniae-induced Stevens-Johnson syndrome without skin lesions: fact or fiction?. J Am Acad Dermatol. 2005, 52:312-5. 10.1016\/j.jaad.2004.07.044","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin S","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. JAMA Dermatol . 1993, 129:92-6. 10.1001\/archderm.1993.01680220104023","journal-title":"JAMA Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer D","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, et al.. U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016, 174:1194-227. 10.1111\/bjd.14530","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): The spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up","volume":"177","author":"Lee HY","year":"2017","unstructured":"Lee HY, Walsh SA, Creamer D. Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): The spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up. Br J Dermatol. 2017, 177:924-35. 10.1111\/bjd.15360","journal-title":"Br J Dermatol"},{"key":"ref15","unstructured":"World Health Organization.International drug monitoring. the role of national centres. (1972). Accessed: September 20, 1971: https:\/\/apps.who.int\/iris\/handle\/10665\/40968."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr T","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010, 5:39. 10.1186\/1750-1172-5-39","journal-title":"Orphanet J Rare Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.99344","article-title":"Phenobarbital induced Stevens-Johnson syndrome in a child","volume":"44","author":"Gaur S","year":"2012","unstructured":"Gaur S, Agnihotri R. Phenobarbital induced Stevens-Johnson syndrome in a child. Indian J Pharmacol. 2012, 44:531-2. 10.4103\/0253-7613.99344","journal-title":"Indian J Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1590\/0034-7167.2014670606","article-title":"[Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a hospital in Distrito Federal]","volume":"67","author":"Emerick MF","year":"2014","unstructured":"Emerick MF, Rodrigues MM, Pedrosa DM, Novaes MR, Gottems LB. [Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a hospital in Distrito Federal]. Rev Bras Enferm. 2014, 67:898-904. 10.1590\/0034-7167.2014670606","journal-title":"Rev Bras Enferm"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt M","year":"2011","unstructured":"Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011, 7:803-15. 10.1586\/eci.11.66","journal-title":"Expert Rev Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2015.12.011","article-title":"Indications for intubation and early tracheostomy in patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis","volume":"211","author":"Williams R","year":"2016","unstructured":"Williams R, Hodge J, Ingram W. Indications for intubation and early tracheostomy in patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Am J Surg. 2016, 211:684-688.e1. 10.1016\/j.amjsurg.2015.12.011","journal-title":"Am J Surg"},{"key":"ref21","article-title":"Necr\u00f3lise Epid\u00e9rmica T\u00f3xica (S\u00edndrome de Lyell): uma patologia para as Unidades de Queimados","volume":"17","author":"Cabral L","year":"2004","unstructured":"Cabral L, Diogo C, Riobom F, Teles L, Cruzeiro C. Necr\u00f3lise Epid\u00e9rmica T\u00f3xica (S\u00edndrome de Lyell): uma patologia para as Unidades de Queimados. Acta Med Port. 2004, 17:129-140.","journal-title":"Acta Med Port"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20176610","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: Epidemiological and clinical outcomes analysis in public hospitals","volume":"92","author":"Arantes LB","year":"2017","unstructured":"Arantes LB, Reis CS, Novaes AG, Carvalho MR, G\u00f6ttems LB, Novaes MR. Stevens-Johnson syndrome and toxic epidermal necrolysis: Epidemiological and clinical outcomes analysis in public hospitals. An Bras Dermatol. 2017, 92:661-7. 10.1590\/abd1806-4841.20176610","journal-title":"An Bras Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death?","volume":"136","author":"Garcia-Doval I","year":"2000","unstructured":"Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death?. Arch Dermatol. 2000, 136:323-7. 10.1001\/archderm.136.3.323","journal-title":"Arch Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01295.x","article-title":"Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: An Asian series","volume":"62","author":"Yip LW","year":"2007","unstructured":"Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, Heng WJ. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: An Asian series. Allergy. 2007, 62:527-31. 10.1111\/j.1398-9995.2006.01295.x","journal-title":"Allergy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113898-steven-johnson-syndrome-in-a-102-year-old-woman-in-saudi-arabia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:07Z","timestamp":1707507847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113898-steven-johnson-syndrome-in-a-102-year-old-woman-in-saudi-arabia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.32303","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,7]]}}}